61
Participants
Start Date
September 4, 2026
Primary Completion Date
May 31, 2030
Study Completion Date
May 31, 2030
ONT01 is a small molecule CD11b modulator.
ONT01 will be administered orally twice daily (in the morning and in the evening at approximately 12 hours apart and approximately the same time each day) and should be taken as whole tablets (not crushed) under fasted conditions (2 hours before and 1 hour after each dose) with 8 oz/240 mL of water.
Hospital for Special Surgery, New York
The University of Texas Medical Branch, Galveston
OTHER
Hospital for Special Surgery, New York
OTHER